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Abstract
Background: Serological tests have long been established as rapid, simple and inexpensive tools for the diagnosis and
follow-up of PCM. However, different protocols and antigen preparations are used and the few attempts to standardize the
routine serological methods have not succeeded.
Methodology/Principal findings: We compared the performance of six Brazilian reference centers for serological diagnosis
of PCM. Each center provided 30 sera of PCM patients, with positive high, intermediate and low titers, which were defined
as the ‘‘reference’’ titers. Each center then applied its own antigen preparation and serological routine test, either
semiquantitative double immunodifusion or counterimmmunoelectrophoresis, in the 150 sera from the other five centers
blindly as regard to the ‘‘reference’’ titers. Titers were transformed into scores: 0 (negative), 1 (healing titers), 2 (active
disease, low titers) and 3 (active disease, high titers) according to each center’s criteria. Major discordances were considered
between scores indicating active disease and scores indicating negative or healing titers; such discordance when associated
with proper clinical and other laboratorial data, may correspond to different approaches to the patient’s treatment.
Surprisingly, all centers exhibited a high rate of ‘‘major’’ discordances with a mean of 31 (20%) discordant scores.
Alternatively, when the scores given by one center to their own sera were compared with the scores given to their sera by
the remaining five other centers, a high rate of major discordances was also found, with a mean number of 14.8 sera in 30
presenting a discordance with at least one other center. The data also suggest that centers that used CIE and pool of
isolates for antigen preparation performed better.
Conclusion: There are inconsistencies among the laboratories that are strong enough to result in conflicting information
regarding the patients’ treatment. Renewed efforts should be promoted to improve standardization of the serological
diagnosis of PCM.
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Introduction
Paracoccidioidomycosis (PCM) is a neglected systemic
fungal infection prevalent mostly in South America. Despite
the significant progress in several areas of knowledge since it
was described by Adolpho Lutz, in 1908, it still shows high
rates of morbidity and mortality and low visibility [1]. In rural
areas of Brazil there are approximately four new cases per
million inhabitants, making it the third cause of death from
chronic infections, with 1.65 cases per million [2].
The gold standard of PCM diagnosis is the visualization of yeast
cells with typical multiple budding aspect in a clinical sample or
isolation of the fungus in culture medium [3]. The latter has either
low sensitivity when samples obtained from non-sterile sites (e.g.,
sputum) are used, or is more sensitive in sterile, deep-seated site
samples, which, however, are not frequently available. In addition,
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the growth of P. brasiliensis can take several weeks [3,4].
Serological tests have been established since the 70’s contributing
to the rapid, simple and inexpensive diagnosis of the mycosis [5–
8].
Several antigenic preparations, including sonicated extracts and
filtered phase concentrated of cultures of the yeast form of the
fungus, have so far been used for the serological diagnosis of PCM
[9]. Early on some authors reported on the issue of variability in
the antigen preparations [10,11]. The growth of yeast cells is
performed in culture media and conditions such as incubation
time, temperature, size of inoculum, with or without agitation, can
lead to differences in the antigens produced in different diagnostic
centers.
In fact, different protocols and antigen preparations are
currently used by these centers for the serological diagnosis
and follow up of patients with PCM. Most centers use
semiquantitative immunoprecipitation techniques, either the
double immunodiffusion (DID) or counterimmunoelectropho-
resis (CIE), or both [7,12–14]. However, their performance is
not routinely checked, in part due to the lack of external
standards. Only an internal positive control is used, which in
most centers is a patient’s serum with a known positive titer.
Moreover, the few attempts put forward to standardize the
routine serological methods used in PCM patients have not
succeeded [15]. One major reason is that the reference centers
have been carrying out in house methodologies for many years
with apparently satisfactory performances [11,15,16]. Howev-
er, unfortunately in most instances these centers do not have
feedback regarding the clinical correlation from the physicians
assisting the patients.
To address this issue, we compared the performance of
laboratories from six medical mycology reference centers in
Brazil that carry out routine serological diagnosis of PCM. The
results show that there are inconsistencies among the laborato-
ries, strong enough to result in conflicting information regarding
the patient’s treatment, and that renewed efforts should be
promoted to improve standardization of the serological diagno-
sis of PCM.
Materials and Methods
Design of the study
Six reference centers that traditionally and routinely perform
serological diagnosis of PCM participated in this study. They all
have made significant scientific contributions to the improvement
of the serological diagnosis of this mycosis and for that reason were
invited to participate in the study: Mycoses Immunodiagnosis
Laboratory, Adolfo Lutz Institute, Sa˜o Paulo (IALSP); Myco-
serology Laboratory, Department of Microbiology, Immunology
and Parasitology, Federal University of Sa˜o Paulo (UNIFESP);
Clinical Mycology Laboratory, Pharmaceutical Sciences School,
Sa˜o Paulo State University (UNESP), Araraquara, SP; Serology
Laboratory, Clinics Hospital, Ribeira˜o Preto School of Medicine
of the University of Sa˜o Paulo (FMRPUSP); Medical Mycology
Laboratory, Laboratory of Teaching and Research in Clinical
Analysis from Maringa´ State (LEPAC); and Medical Mycology
Laboratory Clinics Hospital of the Medical School (LIM53) and
Tropical Medicine Institute, University of Sa˜o Paulo (IMTSP).
Each center was requested to provide 30 sera of PCM patients
from their repository, with positive high, intermediate and low
titers according to their own criteria. The anonymized sera were
numbered 1–30 and aliquots of 120 ml were sent to the remaining
five centers to perform their own serological assays. Thus each
center performed their usual serological assays in 150 sera from 5
different centers blindly with regard to the ‘‘reference’’ titer of the
sera. The results were then sent directly to the coordinating center
(IMTSP), which analyzed the data. In addition, the coordinating
center also provided all centers with aliquots of 6 healthy donor
sera, as negative controls. These donors did not have previous
history of tuberculosis or any other significant infectious disease,
and the sera were non-reactive for PCM and histoplasmosis.
Ethical statement
The study was approved by the Human Research Analysis
Ethics Committee of the Hospital das Clı´nicas da Faculdade de
Medicina da USP, accession number #7915.
Serological assays
All centers employed an immunoprecipitating technique, either
semiquantitative DID [17] or CIE [18]. The isolates used for
antigen preparation are shown in Table 1. Two antigens were
used: (a) the somatic antigen, obtained through sonication (100–
150 W for 309) of the cells grown for 15 days in Fava Netto’s
medium at 35uC [19] and (b) the culture filtrate (metabolic
antigen), obtained from yeast cells grown in Negroni’s medium for
7–10 days (log phase growth) at 37uC [11]. The sonicated antigen
is kept frozen (220uC) while the culture filtrate is stocked at 4uC
[11,19]. Under these conditions, they are stable for several years.
Reactivity of each new batch is tested comparatively with the
previous one using patients’ sera with high, intermediate and low
titers, as well as with a control negative sera and sera from patients
with other fungal infections. Briefly, for the DID, glass slides
(25675 mm) were covered with melted purified agar gel punched
according to a pattern (a central well surrounded by six wells). The
antigen solution was placed in the central well while the peripheral
wells were filled with the patient’s sera and, as a positive control,
either a patient’s serum with a known positive titer or rabbit
hyperimmune serum. Slides were incubated in a moist chamber at
room temperature (20–25uC) and washed with 5% sodium citrate
followed by 0.9% saline. They were dried and stained with
Coomassie Brilliant Blue R (Sigma, USA). The CIE is also based
on the diffusion of proteins but an electric current is applied
through a buffered diffusion medium to accelerate the migration of
Author Summary
Paracoccidioidomycosis (PCM) is a neglected systemic
fungal infection prevalent mostly in South America.
Serological tests have long been established as rapid,
simple and inexpensive tools for the diagnosis and follow-
up of PCM. However, different protocols and reagents are
used. We compared here the performance of six Brazilian
reference centers for serological diagnosis of PCM. Each
center provided 30 sera of PCM patients, with positive
high, intermediate and low titers, which were defined as
the ‘‘reference’’ titers. Each center then applied its
serological routine test to the 150 sera from the other
five centers blindly as regards to the ‘‘reference’’ titers.
Surprisingly, all centers exhibited a high rate of discor-
dances (mean of 31 discordant scores in 150 sera tested).
When the scores given by one center to their own sera
were compared with the scores given to their sera by the
other centers, a high rate of major discordances was found
(a mean of 14.8 sera in 30 presented a discordance with at
least one other center). We concluded that there are
inconsistencies among the laboratories that can potential-
ly result in conflicting information regarding the patient’s
treatment. Renewed efforts should be promoted to
improve standardization of the serological diagnosis of
PCM.
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antibody and antigen, with formation of the precipitation lines
after around one hour. For the CIE, the glass slides were covered
with 1% buffered agarose gel (pH 8.2) and two parallel rows of
wells were punched in the gel. The patient’s serum samples and
positive control were applied to the anodic side and the antigens to
the cathodic side of the slides. All sera were diluted two-fold in
0.9% saline and were tested from the undiluted sample. After
electrophoresis, the slides were washed in 0.9% saline, dried and
stained with Coomassie Brilliant Blue R. The differences in the
protocols used by each center are detailed in Table 1.
Scores and definition of discordances among the
reference centers
All centers provided, as requested, 30 sera of PCM patients
from their repository, collected within the last five years. These
sera were then assayed blindly with regard to their titers by the
other 5 centers. For this, the centers were randomly assigned A to
F and the sera were numbered 1 to 30 by three of the authors
(GMBDN, CPT, GB) who did not participate in the serological
assays. To allow comparison among the centers’ results, titers were
transformed in scores ranging from 0 (negative) to 3 (high titers)
according to each center’s criteria as described in Table 2. Scores
of the sera provided for this study ranged from 1 to 3, with score 1
corresponding to healing titers, and scores 2 and 3 corresponding
to active disease with, respectively, low and high titers.
Each center’s set of sera was assayed by the other five centers.
The results from the donor center, arbitrarily defined as the
reference score for their own sera, were then compared with the
results of the other five centers. Discordance was defined as a
different score, which could be minor, i.e., without a putative
clinical consequence for the patient, or major, when the
discordance could potentially lead to conflicting decisions regard-
ing the patient’s treatment. Minor discordances were between (a)
scores 0 and 1: in both cases, either a negative serological result, or
a low (healing) titer, would suggest inactive disease and both, in
association with clinical and other data, eventually indicate
treatment cessation; or (b) scores 2 and 3, both of which are
associated with active disease. Major discordances were between
scores 2 and 0 or 1, and between 3 and 0 or 1, which, when
associated with proper clinical and other laboratorial data, may
have led to a different treatment of the patient. Comparisons
among laboratories were done using the Chi-square and Fischer
exact test. Differences were considered significant when p,0.05.
Results and Discussion
All centers exhibited a surprisingly high rate of ‘‘major’’
discordances when the scores given by each center to the sera
provided by the other 5 centers were compared with the
‘‘reference’’ scores (Table 3). There was some variability in the
rate of discordances among the centers, ranging from 22 (15%) to
45 (30%) ‘‘major’’ discordant scores out of 150 scores given, and a
mean number of discordant scores of 31 (20%). In fact, the rates of
discordances differed significantly among the centers (p= .0007,
Chi-square). Minor discordances were also highly frequent,
ranging from 16 to 52 out of 150 scores given and a mean of 36
(24%) (Table S1).
Analysis of the performance using the scores given by one center
to their own sera (reference score) and comparing them to the
scores given to their sera by the remaining five other centers,
showed a high rate of major discordances as well (Table 4). For
example, 15 out of the 30 (50%) center A’s reference scores were
discordant with at least one of the remaining centers’ scores, and,
Table 1. Details of the protocols used in the serological assays for paracoccidioidomycosis from the 6 reference centers.
Laboratory
Type of
reaction
Duration of
reaction Type of buffer
Time of washing
in saline
P. brasiliensis isolate(s)
used for Ag preparation
Type of Ag/time of
growth in culture
IMTSP CIE1 90 m Veronal3 48 h IMTSP113/B339/IMTSP135 Crude filtrate/10 days
FMRPUSP CIE 60 m TEB4 24 h Pb18/B339/BAT/BOAS Sonicated/15 days
UNESP CIE 90 m Veronal 12 h B339 Crude filtrate/10 days
LEPAC IDD2 24 h Distilled water 24 h B339 Crude filtrate/7 days
IALSP IDD 48 h Distilled water 24 h B339 Crude filtrate/10 days
UNIFESP IDD 24 h Distilled water 24 h B339 Crude filtrate/10 days
1) Counterimmunoelectrophoresis.
2) Double Immunodiffusion.
3) Veronal buffer;
4) Tris- Borate-EDTA buffer.
doi:10.1371/journal.pntd.0003174.t001
Table 2. Transformation of serological titers of the patients’ sera into scores according to the criteria of each reference center.
Scores
0 1 2 3
Centers Negative Healing titers (inative disease) Low titers (active disease) High titers (active disease)
A, D, E _ 1:1 to 1:2 1:4 to 1:16 $1:32
B, F _ 1:1 to 1:4 1:8 to 1:32 $1:64
C _ 1:1 to1:16 1:32 to 1:64 $1:128
doi:10.1371/journal.pntd.0003174.t002
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eight out of the 30 reference scores (27%) were discordant with
two or more of the remaining centers. Again variability in the rates
of discordance was detected among the centers: in the first
comparison, it ranged from 9 (30%) to 23 (77%) scores (p= .0157,
chi-square) and for the second comparison it ranged from 2 (7%)
to 10 (33%) scores (p.0.05, Chi-square). The mean numbers of
sera presenting a ‘‘major’’ discordance were respectively 14.8 and
7.1. In all, considering the 180 references scores provided by the 6
centers to their own sera, 79 (44%) of them presented a major
discordance with at least one of the other center’s score, and 43
(24%) presented a major discordance with at least two other
centers’ scores (Table 4). Minor discordances were also frequent
when this other analysis was used: for the reference center A,
‘‘minor’’ discordances with at least one other center were found for
19 of their sera (Table S2). In all, 95 of the 180 sera (53%)
presented a ‘‘minor’’ discordance with at least one other
laboratory result (Table S2).
The 6 control negative sera provided by one of the centers were
also negative (score 0) when assayed by the other 5 centers, with
the exception of one serum that received a score 1 (titer 1:2) by
laboratory C. This titer is consistent with a healing titer or a non-
specific reaction according to this laboratory criterion.
Since each lab has its own, in house, assay for detection of anti-
P. brasiliensis antibodies, we anticipated that ‘‘minor’’ discor-
dances (i.e., slight and clinically not relevant differences in the
titers of antibodies) would occur with some frequency. Unexpect-
edly, we found a high rate of ‘‘major’’ discordances (i.e. differences
in scores that may have led to different clinical managements:
maintenance or interruption of the treatment). In an attempt to
understand the reasons for these discrepancies, the influence of
two main variables that discriminated the centers with regard to
their protocols were evaluated, namely the technique employed
(DID [n = 3 centers] vs. CIE [n = 3]) and type of the antigen (single
P. brasiliensis isolate [n = 4 centers] vs. pool of isolates [n = 2]).
Gathering the 150 scores given by each one of the 3 centers
performing the DID technique to the 5 other centers’ sera, of a
total of 450 scores, in 343 instances there was agreement and in
107 major discordance; the same analysis for the 3 centers using
the CIE technique showed more concordant scores (n = 369) and
less discordant scores (n = 81, p= 0.04, Fischer exact test). Among
the 300 scores given by the 2 centers using a pool of isolates, the
proportion was 47 discordant and 253 concordant scores. This
proportion was significantly higher than that obtained with the 4
centers using only one isolate: 141 discordant and 459 concordant
scores (p= 0.007, Fischer exact test). Thus, the type of the reaction
and antigen preparation may be factors that influence the
accuracy of the serological result. Regarding the antigen
preparation, not only gp43, but several other components in both
the somatic and culture filtrate antigens react with the patients’
sera [20,21,22]. The amount of these components in the antigen
preparations not only varies among the strains, but also in a single
strain depending on the number of repeated subculturing, medium
used, log phase of growth when the fungus is harvested, among
other factors. This is probably a major factor in the inconsistencies
among centers. Other particularities that likely influenced the
accuracy of the serological results (such as duration of reaction,
incubation time, expertise and background of the technician
responsible for performing the assay, etc.), could not be assessed in
Table 3. Comparison of the scores from the donor center (reference score) given to their own sera with the scores given by the
other five centers.
n of scores with major discordance with the score provided by each reference center
Centers A B C D E F
A (n= 30) - 5 8 9 6 2
B (n= 30) 11 - 5 7 4 5
C (n=30) 8 3 - 14 7 7
D (n= 30) 13 7 9 - 9 6
E (n= 30) 5 5 3 8 - 2
F (n= 30) 3 3 2 7 8 -
Total 40/150 23/150 24/150 45/150 34/150 22/150
doi:10.1371/journal.pntd.0003174.t003
Table 4. n of major discordant scores with at least one or two other centers.
Centers providers of the sera with reference scores n of major discordant scores with
at least one center at least two centers
A 15/30 8/30
B 14/30 9/30
C 15/30 9/30
D 23/30 10/30
E 9/30 2/30
F 13/30 5/30
Total 89/180 43/180
doi:10.1371/journal.pntd.0003174.t004
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the present study because it was not designed to evaluate these
factors.
The present study demonstrated a high rate of discordance
among centers that are considered to be reference centers for the
diagnosis and serological follow up of PCM patients. Due to the
fact that, per request, only sera from PCM patients were provided
by these centers, we could not analyze the performance of the
serological tests for the diagnosis of PCM. For this, sera of patients
with other mycoses and infectious diseases would also be required.
However, the high rate of discordances found certainly raises some
suspicion with regard to this issue. We illustrate this possibility with
one of the sera from center B, whose donor was a 56 year-old
patient with chronic non-specific respiratory symptoms, initially
and presumptively diagnosed as pulmonary tuberculosis (TB) at a
community health care unit. TB treatment was ineffective, the
pulmonary symptoms worsened and he developed a pneumotho-
rax. Microbiological evaluation was negative on both sputum and
bronchoalveolar lavage. Diagnosis of PCM was made based on the
history of having lived in an endemic area, a suggestive chest X-
ray, and a 1:32 titer on the CIE test for PCM (score 2, active
disease). A similar active disease score was given by centers E and
F, but centers A, C and D gave titers corresponding to score 1 (1:1,
1:8 and 1:2, respectively), suggestive of healing disease, which
could potentially delay the diagnosis and the beginning of
antifungal treatment.
Relapses and recrudescence are commonly reported during the
prolonged (usually .1 year) antifungal therapy of this mycosis. In
Argentina, Negroni et al [23] reported that 14.3% of the patients
relapsed after a follow up of 15 months. In Brazil, Marques
reported 13.8% of relapses after 10 years of follow up, although
almost half of the relapses occurred in the first 3 years, when the
patients were still on or just off antifungal therapy [24]. Serological
follow up has been shown to be an important tool in the early
diagnosis of relapses [13,14,25]. The factor most commonly
reported as contributing to the failure of the anti-fungal treatment
is poor compliance due to socio-economical factors such as
alcoholism, unemployment and/or long distance from the local
drug provider [26]. Although decisions regarding the interruption
or prolongation of drug therapy are not made solely based on the
serological result, we speculate that in certain cases the relapses
would be related to inadvertent therapy discontinuation due to
misleading serological monitoring. On the other hand, some
patients may undergo unnecessary prolongation of the antifungal
therapy. In any case, it is clear from the present study that an effort
from the medical mycology community must be undertaken (or re-
undertaken) to improve better standardization of the serological
diagnosis of this mycosis. Our results suggest that particularly the
type of antigen (pool vs. single isolate) and technique (DID vs. CIE)
should be addressed.
Efforts should also be made at the same time to develop and
standardize P. lutzii serological diagnosis tests. This is a new
species in the Paracoccidioides genera recently described that is
endemic in some areas of South America where the patients’ sera
were reported to not recognize the P. brasiliensis’ antigens in
conventional serological tests [27–29]. This issue could not be
addressed here since the 6 reference centers participating in the
study were located in P. brasiliensis endemic areas and provided
sera only with positive serological results. However, occasionally
reference centers outside P. lutzii endemic areas may handle sera
from PCM due to P. lutzii and release false negative serological
results. This has already been documented [30] and will certainly
be more common owing to the increasing migration rates in South
American countries, particularly Brazil.
Finally, high discordance rates may well occur in the diagnosis
of other endemic mycoses such as histoplasmosis, coccidioidomy-
cosis and blastomycosis, all of which are endemic in some areas of
South America and that are covered by the reference centers
involved in this study or by other reference centers. The efforts to
improve the serological diagnosis should also be addressed for
these mycoses that, like PCM, remain among the most neglected
diseases in South America.
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